Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara E Mahon

Showing results (61-70 of 86) with videos related to

Pageof 9
Sort By:
The Lancet. Microbe|May 11, 2022
Estimation of the correlates of protection of the rVSVΔG-ZEBOV-GP Zaire ebolavirus vaccine: a post-hoc analysis of data from phase 2/3 clinical trialsRebecca F Grais, Stephen B Kennedy, Barbara E Mahon, et al.
The Journal of Infectious Diseases|May 20, 2021
Baseline Asymptomatic Malaria Infection and Immunogenicity of Recombinant Vesicular Stomatitis Virus-Zaire Ebola Virus Envelope GlycoproteinBarbara E Mahon, Jakub Simon, Marc-Alain Widdowson, et al.
Vaccine|October 8, 2022
Immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccine (ERVEBO®) in African clinical trial participants by age, sex, and baseline GP-ELISA titer: A post hoc analysis of three Phase 2/3 trialsJakub K Simon, Stephen B Kennedy, Barbara E Mahon, et al.
MMWR. Morbidity and Mortality Weekly Report|August 24, 2023
Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023Jefferson M Jones, Katherine E Fleming-Dutra, Mila M Prill, et al.
MMWR. Morbidity and Mortality Weekly Report|June 23, 2022
Dispensing of Oral Antiviral Drugs for Treatment of COVID-19 by Zip Code-Level Social Vulnerability - United States, December 23, 2021-May 21, 2022Jeremy A W Gold, James Kelleher, Jake Magid, et al.
Infectious Diseases in Obstetrics and Gynecology|March 19, 2015
Estimating the attack rate of pregnancy-associated listeriosis during a large outbreakMaho Imanishi, Janell A Routh, Marigny Klaber, et al.
MMWR. Morbidity and Mortality Weekly Report|August 18, 2022
Summary of Guidance for Minimizing the Impact of COVID-19 on Individual Persons, Communities, and Health Care Systems - United States, August 2022Greta M Massetti, Brendan R Jackson, John T Brooks, et al.
Archives of Pediatrics & Adolescent Medicine|August 8, 2012
Infections in pediatric postdiarrheal hemolytic uremic syndrome: factors associated with identifying shiga toxin-producing Escherichia coliRajal K Mody, Ruth E Luna-Gierke, Timothy F Jones, et al.
Vaccine|June 28, 2019
An online decision tree for vaccine efficacy trial design during infectious disease epidemics: The InterVax-ToolSteven E Bellan, Rosalind M Eggo, Pierre-Stéphane Gsell, et al.
Emerging Infectious Diseases|November 22, 2011
Risk factors early in the 2010 cholera epidemic, HaitiKatherine A O'Connor, Emily Cartwright, Anagha Loharikar, et al.
Pageof 9

Showing results (61-70 of 86) with videos related to

Sort By:
Pageof 9
The Lancet. Microbe|May 11, 2022
Estimation of the correlates of protection of the rVSVΔG-ZEBOV-GP Zaire ebolavirus vaccine: a post-hoc analysis of data from phase 2/3 clinical trialsRebecca F Grais, Stephen B Kennedy, Barbara E Mahon, et al.
The Journal of Infectious Diseases|May 20, 2021
Baseline Asymptomatic Malaria Infection and Immunogenicity of Recombinant Vesicular Stomatitis Virus-Zaire Ebola Virus Envelope GlycoproteinBarbara E Mahon, Jakub Simon, Marc-Alain Widdowson, et al.
Vaccine|October 8, 2022
Immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccine (ERVEBO®) in African clinical trial participants by age, sex, and baseline GP-ELISA titer: A post hoc analysis of three Phase 2/3 trialsJakub K Simon, Stephen B Kennedy, Barbara E Mahon, et al.
MMWR. Morbidity and Mortality Weekly Report|August 24, 2023
Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023Jefferson M Jones, Katherine E Fleming-Dutra, Mila M Prill, et al.
MMWR. Morbidity and Mortality Weekly Report|June 23, 2022
Dispensing of Oral Antiviral Drugs for Treatment of COVID-19 by Zip Code-Level Social Vulnerability - United States, December 23, 2021-May 21, 2022Jeremy A W Gold, James Kelleher, Jake Magid, et al.
Infectious Diseases in Obstetrics and Gynecology|March 19, 2015
Estimating the attack rate of pregnancy-associated listeriosis during a large outbreakMaho Imanishi, Janell A Routh, Marigny Klaber, et al.
MMWR. Morbidity and Mortality Weekly Report|August 18, 2022
Summary of Guidance for Minimizing the Impact of COVID-19 on Individual Persons, Communities, and Health Care Systems - United States, August 2022Greta M Massetti, Brendan R Jackson, John T Brooks, et al.
Archives of Pediatrics & Adolescent Medicine|August 8, 2012
Infections in pediatric postdiarrheal hemolytic uremic syndrome: factors associated with identifying shiga toxin-producing Escherichia coliRajal K Mody, Ruth E Luna-Gierke, Timothy F Jones, et al.
Vaccine|June 28, 2019
An online decision tree for vaccine efficacy trial design during infectious disease epidemics: The InterVax-ToolSteven E Bellan, Rosalind M Eggo, Pierre-Stéphane Gsell, et al.
Emerging Infectious Diseases|November 22, 2011
Risk factors early in the 2010 cholera epidemic, HaitiKatherine A O'Connor, Emily Cartwright, Anagha Loharikar, et al.
Pageof 9